向缺氧外体IGFBP2克服了CD47介导的免疫逃避在质母细胞瘤
Yanhua Qi1,2, Rongrong Zhao1,2, Xinglong Zhang1,2
1Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, 250012, Shandong, P. R. China.
缺氧驱动胰岛素样生长因子结合蛋白2 (IGFBP2) 和质母细胞瘤 (GBM) 中的CD47表达,促进免疫逃避. 阻断IGFBP2和CD47协同抑制GBM生长,提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 质母细胞瘤 (GBM) 表现出免疫逃避,通常与缺氧和CD47过度表达有关.
- 缺氧影响CD47介导的免疫逃避的确切机制尚未完全理解.
研究的目的:
- 调查低氧驱动器在协调CD47依赖性免疫逃避中的作用.
- 在低氧条件下识别参与GBM免疫逃避的分子参与者.
主要方法:
- 集成的单细胞RNA测序和蛋白质组分析,以识别低氧性GBM中共同表达的基因.
- 研究了缺氧诱导的IGFBP2表达和外体细胞分泌机制.
- 采用了基因组 GBM 模型来评估联合 IGFBP2 和 CD47 阻断的疗效.
主要成果:
- 胰岛素类生长因子结合蛋白2 (IGFBP2) 在低氧性GBM中与CD47共同表达,促进瘤进展和免疫逃避.
- 缺氧通过HIF-2α诱导IGFBP2,并通过HIF-1α/RAB3A.A增强外体分泌.
- 外体IGFBP2激活整合蛋白/FAK/STAT3信号,增加CD47和抑制巨细胞灭菌.
- 血清外体IGFBP2水平与GBM等级相关,作为潜在的诊断生物标志物.
- 在GBM模型中,IGFBP2和CD47的联合阻断协同抑制了瘤生长和改善了生存率.
结论:
- 发现了一种新的缺氧-外体IGFBP2-CD47信号轴,对GBM免疫规避至关重要.
- 这一轴为组合疗法提供了一个有前途的治疗标,以提高质母细胞瘤免疫疗法的疗效.
更多相关视频
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
08:13Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
相关概念视频
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
What is the Immune System?
Humoral Immune Responses
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
